PRECEDE: A Global Effort to Increase Screening for High-Risk Pancreatic Cancer
Sacituzumab Tirumotecan for Gastric Cancer With TROP2 expression: The KL264-01 Trial
Liquid Biopsy With Biomarker CA 19-9 Accurately Detects Early-Stage Pancreatic Cancer